One thing is essential for the pharmaceutical industry—materials. There is no time being wasted by pharmaceutical companies when it comes to developing generic drugs or innovative drugs.
Unprecedented challenges that procurement teams have encountered in the past couple of years.The impact of the global supply chain disruptions, regulatory measures, raw material shortages, transportation delays and geopolitical risk has created a vulnerability throughout the pharmaceutical supply networks. A small number of suppliers or lack of visibility of a supply chain proved to be serious business risks for many organisations.
This is why the pharmaceutical sector is turning its attention to API Supply Chain Intelligence in order to improve procurement ‘resilience’ and continuity of business.
No longer are companies reactive when faced with a disruption, but rather proactive in using intelligence based on data to identify and analyze potential risks ahead of time and make sound sourcing decisions.
API Supply Chain Intelligence refers to the collection and analysis of supplier, manufacturing, regulatory, logistical and market information to make more informed sourcing decisions and mitigate risk.
It offers a detailed knowledge of factors affecting API availability and supplier reliability to procurement teams.
Rather than relying on just the suppliers themselves, supply chain intelligence provides a view into the entire supply chain environment for API manufacturing and distribution.
The intelligence that may be included is:
Drug Master File (DMF) information
This information can be brought together and provide procurement teams with more visibility and the ability to act in a way to adapt to market conditions.
The significance of procuring Resilience in pharmaceutical sourcing. Why is Procurement Resilience important in the Sourcing of Pharmaceuticals?
Procurement resilience is defined by the capacity of an organization to maintain the continuous provision of crucial raw materials during any disruption.
The pharmaceutical industry in particular requires resilience because of the potential effects it can have on the production process as well as the delivery of drugs and vaccines to patients.
Procurement resilience is growing in significance due to several factors:
Many pharmaceutical companies are using APIs from multiple countries. This widens the sourcing opportunities but also increases the likelihood of geopolitical issues, trade restrictions and transport issues.
Regulatory inspection, warning letter, import alerts and compliance problems can make a big difference in supplier availability.
A seemingly reliable supplier today could trigger unexpected sourcing issues because of potential future regulatory issues.
Significant pharmaceutical companies rely on just a few suppliers for vital APIs. A disruption in one part of the supply chain can impact the whole chain if the supply chain is impacted.
API availability and pricing can change rapidly due to demand variations, raw material scarcity and production limitations.
Without visibility of these changes, it can be difficult for organisations to act quickly.
This is why the goals of the pharmaceutical procurement team can be termed as procurement resiliency.
API Supply Chain Intelligence – How to Make Procurement More Resilient
The benefit of API Supply Chain Intelligence is that it can detect risks that may hinder operations.
Business teams can track metrics like:
Organizations don't need to just find out about problems when supply issues are occurring, they can take measures and prepare contingency plans.
This anticipatory strategy is a key element in minimizing operational risk.
A large number of pharmaceutical companies only have visibility into their immediate suppliers.
However, the interruption of supply can typically come from further downstream in the supply chain.
With API Supply Chain Intelligence, procurement teams can gain insight into:
This increased visibility helps companies find vulnerabilities and plan for a more secure supply chain.
As an instance, there might be several suppliers utilizing the exact same region of manufacturing or raw material origin, and procurement teams can be aware of the potential concentration risk in advance of it occurring into a big issue.
In times of disruption, speed is a major key.
Businesses that can rapidly locate and recruit qualified substitutes will be in a stronger position to ensure that they produce, rather than suffer a shortage.
By keeping a properly updated Global API Supplier List, procurement teams have access to more qualified suppliers from various regions.
During crisis, organizations don't have to begin a new search of suppliers but can quickly assess their options for sourcing from other suppliers.
The function has become more critical in recent times, especially for the pharmaceutical sector, where supply chains are becoming more volatile.
You need to be able to choose the right supplier more than just because of price.
When a procurement team is forming, they need to consider the following:
API Supply Chain Intelligence is the data that allows you to make informed qualification decisions.
Instead of being limited in information, organisations can compare suppliers on various aspects, and minimise qualification risks.
This helps to improve the relationship with suppliers and create more consistent sourcing results.
Supply chain intelligence helps to improve supply chain planning throughout the procurement process.
Knowing the trend of the market, the capabilities of suppliers, and the factors of risk, organizations can:
Avoiding the need to make last-minute sourcing decisions reduces the risk and expense.
Manually handling supplier intelligence can be a challenge.
A procurement team will have to deal with a significant amount of data from suppliers on spreadsheets, email, regulatory documentation and internal systems.
A Top Pharmaceutical API Suppliers Database can serve to centralize this data and make it easy to access.
When a modern API sourcing platform is compared to a listing of suppliers, it is more than just that; you're getting a full-fledged intelligence environment for procurement.
The following information is often found in these databases:
Profiles of global API suppliers.
Having key sourcing data in one place allows procurement teams to make better, quicker decisions.
A centralized database can further facilitate supplier diversification initiatives as organizations would be able to find new suppliers and have a better understanding of alternative supplier options.
A dependable supplier intelligence platform can prove to be a major advantage for companies that are keen on procurement resilience.
Procurement resilience is not a one-off initiative. It requires constant supplier visibility, risk management and intelligence-based decision making.
There are some areas to work on if an organisation wants to build resilience.
Having a single supplier means that the risk exposure is also high.
Having several qualified suppliers allows you to gain sourcing flexibility and lessen dependency.
Increase supplier performance monitoring on a regular basis.Monitor supplier performance on a continuous basis.
Supplier qualification should not stop with the onboarding!
Monitoring of supplier performance, regulatory status and operational capability is a way of helping organizations identify emerging risks regularly.
Having the right supplier details enables quicker decision-making and risk management.
The utilization of centralized intelligence platforms can aid procurement teams in accessing accurate and timely data.
Sometimes, disruptions in supplies cannot be prevented.
Companies should create contingency sourcing plans and find new sources of supply ahead of time.
The most resilient companies use intelligence in their decision making process while making sourcing decisions; this is not just based on previous relations and price.
Data driven sourcing increases visibility and removes uncertainties and improves procurement performance.
Procurement resilience is a must for the contemporary pharmaceutical sector. With the recent turbulence in the global business environment, the need for proper risk management has become one of the key aspects of proper sourcing.
The API Supply Chain Intelligence enables procurement departments to see and to foresee the risks, to choose a supplier, to evaluate the alternatives and to make informed decisions.
Supplier intelligence, regulatory intelligence, market intelligence, and supply chain visibility when combined can turn sourcing into proactive activities.
A top pharmaceutical API suppliers database and a comprehensive global API supplier List further supports this capability by assisting procurement teams in finding API suppliers, risk assessment and supply continuity.
With the ongoing shift in the pharmaceutical supply chain, companies who invest in intelligent procurement will thrive in developing resilient, reliable and competitive sourcing operations.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!